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http://dxObjective: Left ventricular dysfunction and preoperative hyponatremia are associated with adverse outcomes
after cardiac surgery. However, the interactions between them are unknown. Thus, we evaluated the interaction
of low left ventricular ejection fraction (<40%) and preoperative hyponatremia (Na<135 mEq/L) with morbid-
ity and mortality after cardiac surgery.
Methods: The interaction of hyponatremia and ejection fraction with hospital complications, length of stay, and
mortality was analyzed using logistic and Cox regression analysis in 2247 patients who underwent cardiac
surgery between 2005 and 2008 at The Ohio State University Wexner Medical Center.
Results:Of the patients, 68.5% had normal ejection fraction. Hyponatremia was present in 18% of patients with
normal ejection fraction and 35% of patients with low ejection fraction. Hyponatremic patients had higher rates
of New York Heart Association class III and IV, more comorbidities, and higher Society of Thoracic Surgeons
score and European System for Cardiac Operative Risk Evaluation irrespectively of their ejection fraction. The
correlation between preoperative sodium and ejection fraction was weak (r2 ¼ 0.04). Hyponatremia increased
the rate of postoperative complications and hospital stay, and decreased 1- and 3-year survivals in patients with
both normal and low ejection fraction. Hyponatremia was independently associated with longer hospital stay for
normal ejection fraction (multiplier, 1.18; confidence interval, 1.09-1.27; P<.001) and low ejection fraction
(multiplier, 1.10; confidence interval, 1.0-1.21; P¼ .05), increased need for dialysis for normal ejection fraction
(odds ratio, 2.16; confidence interval, 1.08-4.32; P ¼ .03), and increased risk of mortality for normal ejection
fraction (hazard ratio, 1.56; confidence interval, 1.20-2.05; P ¼ .001), but not for patients with low ejection
fraction (hazard ratio, 1.21; confidence interval, 0.89-1.65; P ¼ .21).
Conclusions: Hyponatremia is more common in patients with low ejection fraction. Although preoperative
hyponatremia is independently associated with adverse outcomes in patients with normal ejection fraction,
an association with adverse outcomes in patients with low ejection fraction was not demonstrated. (J Thorac
Cardiovasc Surg 2013;145:1589-94)MSupplemental material is available online.PHyponatremia is a common electrolyte abnormality in crit-
ically ill patients and adversely affects outcomes.1,2 It is
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The Journal of Thoracic and Carfailure, in whom its prevalence and severity correlate
with the prevalence and severity of heart failure and
ventricular dysfunction.3-5 We previously demonstrated
that preoperative hyponatremia is common before cardiac
surgery and is an independent risk factor for mortality,
prolonged hospitalization, and postoperative complications
after cardiac surgery.6 Left ventricular (LV) dysfunction is
also an independent predictor of poor outcomes after cardiac
surgery. It has been associated with increased morbidity and
mortality after coronary artery bypass surgery, valve sur-
gery, combined bypass and valve surgery, and other cardiac
surgery procedures.7-10
The interaction between preoperative hyponatremia and
LV dysfunction and its effects on outcomes after cardiac
surgery have not been evaluated. We hypothesize that hypo-
natremia may potentiate the adverse effect of LV dysfunc-
tion in outcomes after cardiac surgery. We retrospectively
studied 2247 patients undergoing cardiac surgery to deter-
mine the prevalence of preoperative hyponatremia in pa-
tients with LV dysfunction before cardiac surgery and the
interaction between preoperative hyponatremia and LVdiovascular Surgery c Volume 145, Number 6 1589
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
EF ¼ ejection fraction
LV ¼ left ventricular
NYHA ¼ New York Heart Association
STS ¼ Society of Thoracic Surgeons
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Mdysfunction on hospital complications and on short- and
long-term mortality after cardiac surgery.MATERIALS AND METHODS
From January 2005 to December 2008, 2785 patients underwent cardiac
surgery procedures at The Ohio State University Wexner Medical Center.
Preoperative serum sodium and LV ejection fraction (EF) determinations
were available in 2247 patients. These patients constitute the study popula-
tion. Hyponatremia was defined as serum sodium less than 135 mEq/L in
any of the 3 most recent daily sodium determinations performed within
30 days before surgery. Systolic LV dysfunction was defined as an LV EF
less than 40%. LVEFwas assessed by ventriculogram in 63.6% of patients,
echocardiogram in 35.5% of patients, and other methods in 0.9% of pa-
tients. Patients were divided into 4 groups according to EF and hyponatre-
mia status: (1) low EF (EF<40%) and normonatremia (Na 135 mEq/L)
group, (2) low EF (EF<40%) and hyponatremia (Na<135 mEq/L) group,
(3) normal EF (EF 40%) and normonatremia (Na 135 mEq/L) group,
and (4) normal EF (EF40%) and hyponatremia (Na<135 mEq/L) group.
Data from the institution electronic medical records, the institution Soci-
ety ofThoracic Surgeons (STS) database, and theSocialSecurityDeath Index
were analyzed. Outcomes analyzed included early and latemortality, postop-
erative length of hospital stay, incidence of STS-defined complications,11,12
and need for perioperative blood transfusions. Outcomes definitions are
listed inAppendix E1. TheOhio State UniversityWexnerMedical Center In-
stitutional Review Board approved this study and granted waiver of Health
Insurance Portability and Accountability Act research authorization.
Statistical Analysis
Baseline characteristics are presented as means, standard deviations,
medians, and interquartile ranges for continuous variables. Categoric vari-
ables are presented as frequencies. Baseline characteristics were compared
using Pearson’s chi-square test for categoric variables and Kruskal–Wallis
for continuous variables. Regression models were developed using a risk
factor modeling approach to determine which covariates were included
in the model.13,14 Covariates that acted as a confounder or an effect
modifier were included (Appendix E2). Logistic regression was used to
find the association between hyponatremia and EF status with STS compli-
cations. Logistic regression was used when the outcome was early mortal-
ity. Linear regression was used when the outcome was log-transformed
hospital length of stay. Cox proportional hazard regression was used to
find the association of late and overall mortality with hyponatremia and
EF status. Serum sodium was treated as both a continuous and a dichoto-
mous variable. Survival was estimated by the Kaplan–Meier method, and
differences in survival were compared using the log-rank test. All analyses
were conducted using Stata 11.1 (StataCorp LP, College Station, Tex).RESULTS
Preoperative hyponatremia was present in 527 patients
(23.5%) before cardiac surgery. The distribution of preoper-
ative EF is shown in Figure E1. Low EF was present in 7071590 The Journal of Thoracic and Cardiovascular Surpatients (31.5%). A total of 282 patients (18.3%) in the nor-
mal EF group and 245 patients (34.6%) in the low EF group
had preoperative hyponatremia. Hyponatremic and normo-
natremic patients had clinically similar EF within their EF
group (Table 1). The correlation between preoperative serum
sodium and preoperative EF was weak (r2 ¼ 0.04).
Demographics, clinical, and surgical characteristics are
shown in Table 1. Compared with those with normal EF,
patients with low EF were younger and more often male.
They more often had congestive heart failure and a higher
prevalence of myocardial infarction, chronic obstructive
pulmonary disease, stroke, peripheral vascular disease, dia-
betes, renal dysfunction, and previous cardiac surgery.
These comorbidities resulted in higher predicted risk of
mortality as determined by European System for Cardiac
Operative Risk Evaluation and STS Predicted Risk of Mor-
tality. Hyponatremic patients had a higher rate of New York
Heart Association (NYHA) functional class III and IV,
higher rate of previous cardiac surgery, and higher Euro-
pean System for Cardiac Operative Risk Evaluation irre-
spectively of their EF status.
Isolated coronary artery bypass grafting (CABG) and iso-
lated valve surgery were more common in the normal EF
group, and combined CABG-valve, ventricular assist device,
and other cardiac surgery procedures were more common in
the low EF group. Cardiopulmonary bypass time and cross-
clamp times were not clinically different among the groups.
Table 2 shows unadjusted clinical outcomes. The rate of
postoperative complications (operative, infectious, pulmo-
nary, renal failure, need for dialysis, and other complica-
tions) was higher in the low EF group. Hyponatremia
increased the incidence of operative, pulmonary, and renal
complications compared with normonatremia in both the
normal and low EF groups. Low EF was associated with
longer hospital stay. Hyponatremia increased the length of
hospital stay in both the normal and low EF groups. Early
and late mortality were increased in the low EF group com-
pared with the normal EF group (early mortality: 8.5% vs
3.9% in normal EF, P< .001; late mortality: 20.4% vs
13.2% in normal EF, P<.001). Hyponatremia further in-
creased early and late mortality in both the normal and
low EF groups (Table 2). Kaplan–Meier survival curves
by hyponatremia and EF status are shown in Figure 1. Me-
dian follow-up was 1.31 years (interquartile range, 0.2-
2.58). Hyponatremia decreased the estimated 1- and
3-year survivals in both the normal EF and low EF groups
compared with normonatremia.
Figure E2 shows a univariate analysis of the clinical out-
comes. Hyponatremia increased the odds of operative, pul-
monary, and renal complications; renal failure requiring
dialysis; length of hospital stay; and early mortality in both
the low and normal EF cohorts. It also increased the hazard
of late and overall mortality in both groups. After adjusting
for baseline and procedural variables (Figure 2),gery c June 2013
TABLE 1. Patients’ clinical characteristics and operative variables stratified according to preoperative left ventricular ejection fraction and serum
sodium
Low EF N ¼ 707 Normal EF N ¼ 1540
P normal
vs low EFNa 135 mEq/L Na<135 mEq/L
P Na<135
mEq/L
vs Na 135
mEq/L Na 135 mEq/L Na<135 mEq/L
P Na<135
mEq/L
vs Na 135
mEq/L
N 462 245 — 1258 282 — —
Mean Na  SD (mEq/L) 138.5  2.2 133.2  3.0 <.001 138.7  1.8 133.9  2.4 <.001 <.001
Age (y) 61  12 59  12 .004 62  13 63  14 .117 .004
Male gender, N (%) 324 (70.1) 175 (71.4) .718 825 (65.6) 173 (61.4) .179 .007
White race, N (%) 383 (82.9) 196 (80.0) .341 1094 (87.0) 236 (83.7) .147 .006
LV EF (%, mean  SD) 26  8 24  9 <.001 53  7 53  8 .067 N/A
Mean PA pressure
(mm Hg, mean  SD)
32.3  10.8 32.8  9.6 .380 27.0  9.5 32.0  13.4 <.001 <.001
GFR (mg/min/1.73 m2) 69  29 64  29 .094 73  26 74  32 .754 .001
NYHA class III-IV (%) 356 (77.1) 204 (83.4) .050 689 (54.8) 192 (68.2) <.001 <.001
Diabetes, N (%) 203 (43.9) 115 (46.9) .446 423 (33.6) 134 (47.5) <.001 <.001
Hypertension, N (%) 393 (85.1) 196 (80.0) .086 1035 (82.3) 249 (88.3) .014 .968
Renal failure on dialysis,
N (%)
57 (12.3) 42 (17.0) .260 86 (6.8) 30 (10.7) .150 .002
Previous MI, N (%) 286 (61.9) 152 (62.0) .972 452 (35.9) 116 (41.1) .102 <.001
COPD, N (%) 147 (31.8) 99 (40.4) .022 292 (23.2) 84 (29.7) .020 <.001
Stroke, N (%) 75 (16.2) 42 (17.2) .864 157 (12.5) 37 (13.2) .864 .017
PVD, N (%) 94 (20.4) 58 (23.7) .367 199 (15.8) 59 (20.9) .038 .009
Previous cardiac surgery,
N (%)
59 (12.8) 47 (19.2) .023 127 (10.1) 45 (16.0) .005 .011
euroSCORE,% (IQR) 29 (12-54) 46 (23-71) <.001 10 (4-27) 19 (6-45) <.001 <.001
STS PROM,% (IQR) 2.68 (1.17-5.99) 2.95 (1.54-6.66) .337 1.23 (0.62-2.83) 1.53 (0.69-4.69) .011 <.001
Surgical characteristics
CPB time, min  SD 130  53 125  67 .128 117  57 126.0  64 .134 <.001
Crossclamp time,
min  SD
98  39 95  45 .307 91  43 96  49 .485 .001
CABG only, N (%) 179 (38.7) 65 (26.5) .001 629 (50.0) 130 (46.1) .236 <.001
Valve surgery only, N (%) 52 (11.3) 23 (9.4) .443 182 (14.5) 46 (16.3) .431 .007
CABG valve, N (%) 100 (21.6) 33 (13.5) .008 125 (9.9) 42 (14.9) .016 <.001
VAD surgery only, N (%) 11 (2.4) 29 (11.8) <.001 2 (0.2) 0 (0) .503 <.001
Other surgery, N (%) 120 (26) 22 (9.0) <.001 320 (25.4) 64 (22.7) .33 .013
EF, Ejection fraction; SD, standard deviation; LV, left ventricular; PA, pulmonary artery; GFR, glomerular filtration rate; NYHA, New York Heart Association; MI, myocardial
infarction; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; euroSCORE, European System for Cardiac Operative Risk Evaluation; IQR, inter-
quartile range; STS PROM, Society of Thoracic Surgeons Predicted Risk of Mortality; CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting; VAD, ventricular
assist device; N/A, not available.
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Mhyponatremia was associated with increased length of hospi-
tal stay for normal EF (multiplier, 1.18; confidence interval
[CI], 1.09-1.27; P<.001) and low EF (multiplier, 1.10; CI,
1.00-1.21; P¼ .05) cohorts. The odds of dialysis (odds ratio,
2.16; CI, 1.08-4.32; P¼ .03) and early mortality (odds ratio,
1.93; CI, 1.00-3.69; P¼ .047), and the hazard of late (hazard
ratio, 1.54; CI, 1.13-2.11; P ¼ .008) and overall mortality
(hazard ratio, 1.56; CI, 1.20-2.05; P ¼ .01) were increased
by hyponatremia for patientswith normal EF. After adjusting
for baseline and operativevariables, hyponatremia did not in-
crease early, late, or overall mortality in the low EF cohort.
Figure 3 displays the adjusted overall mortality in func-
tion of serum sodium as a continuous variable for low and
normal EF cohorts. The adjusted mortality rate increasesThe Journal of Thoracic and Carwith the severity of preoperative hyponatremia in those
with normal EF but not in those with low EF.
DISCUSSION
This study demonstrated that (1) preoperative hyponatre-
mia is approximately twice as frequent in patients with low
EF than in patients with normal EF, (2) there is not a strong
direct correlation between EF and preoperative serum
sodium, (3) preoperative hyponatremia increases the unad-
justed rate of postoperative complications and mortality and
decreases long-term survival for patients with normal EF
and patients with low EF, and (4) preoperative hyponatre-
mia increases the hazard of mortality for patients with nor-
mal EF. However, preoperative hyponatremia was notdiovascular Surgery c Volume 145, Number 6 1591
TABLE 2. Unadjusted clinical outcomes stratified by preoperative left ventricular ejection fraction and serum sodium
Low EF N ¼ 707 Normal EF N ¼ 1540
P normal
vs low EFNa 135 mEq/L Na<135 mEq/L
P Na<135
mEq/L
vs Na 135
mEq/L Na 135 mEq/L Na<135 mEq/L
P Na<135
mEq/L
vs Na 135
mEq/L
N 462 245 — 1258 282 — —
Complications
Operative, N (%) 57 (12.3) 55 (22.5) <.001 103 (8.2) 35 (12.4) .0250 <.001
Infectious, N (%) 32 (6.9) 20 (8.2) .549 36 (2.9) 17 (6.0) .0110 <.001
Pulmonary, N (%) 138 (29.9) 117 (47.8) <.001 283 (22.5) 92 (32.6) <.001 <.001
Neurologic, N (%) 12 (2.6) 11 (4.5) .177 34 (2.7) 8 (2.8) .9000 .49
Renal failure, N (%) 39 (8.4) 37 (15.1) .007 73 (5.8) 39 (13.8) <.001 .006
Dialysis, N (%) 24 (5.2) 24 (9.8) .021 39 (3.1) 25 (8.9) <.001 .008
Other, N (%) 134 (29.0) 72 (29.4) .915 328 (26.1) 90 (31.9) .0460 .327
Blood transfusion 219 (47.5) 142 (57.9) .009 513 (40.8) 162 (57.5) <.001 .002
Hospital LOS, d (IQR) 11.5 (7.61-17.9) 18.2 (10.9-12.8) <.001 8.28 (6.12-12.8) 11.6 (7.72-19.0) <.001 <.001
Mortality
Early mortality, N (%) 30 (6.5) 30 (12.2) .009 40 (3.2) 20 (7.1) .0020 <.001
Late mortality, N (%) 84 (18.2) 60 (24.5) .047 146 (11.6) 57 (20.2) <.001 <.001
Early mortality: any death during the hospitalization for surgery or after discharge from the hospital, but within 30 days of the procedure. Late mortality: any death after discharge
from the hospital and more than 30 days from the operative procedure. For definitions of complications see Appendix E1. EF, Ejection fraction; LOS, length of stay; IQR, in-
terquartile range.
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Mindependently associated with an increased hazard of mor-
tality in those with low EF.
Hyponatremia is common in patients with heart failure
and patients with LV dysfunction.3-5 The prevalence of
hyponatremia in heart failure ranges from 5% in
outpatients to 27% in hospitalized patients.1,3-5 The
present study reported for the first time the prevalence of
preoperative hyponatremia in patients with normal and
decreased LV function in need of cardiac surgery. The
overall prevalence was similar to that of patients
hospitalized with heart failure.4,15 However, theFIGURE 1. Kaplan–Meier survival curve stratified according to preoperative s
vivals for both the low and normal EF cohorts (log-rank P<.001). One-year surv
greater versus 70% (95% CI, 63-75) for Na less than 135 mEq/L. One-year surv
or greater versus 79% (95%CI, 74-84) for Na less than 135 mEq/L. Three-year
or greater versus 56% (95% CI, 48-63) for Na less than 135 mEq/L. Three-yea
mEq/L or greater versus 62% (95% CI, 55-69) for Na less than 135 mEq/L. E
1592 The Journal of Thoracic and Cardiovascular Surprevalence of hyponatremia in patients with low EF was
twice as high as that in patients with normal EF. The high
prevalence of preoperative hyponatremia in patients with
LV dysfunction waiting for cardiac surgery reflects
a more advanced stage of cardiac disease and higher
prevalence of associated comorbidities (Table 1).
Previous studies have demonstrated that hyponatremia is
a marker of disease severity in congestive heart failure with
and without depressed LV EF.1,3,5,16 The current study did
not find a strong correlation between serum sodium and
LV EF. In addition, EF was similar in patients with andodium level and EF. Hyponatremia decreased 1- and 3-year unadjusted sur-
ival for the low EF cohort was 82% (95% CI, 78-86) for Na 135 mEq/L or
ival for the normal EF cohort was 88% (95% CI, 86-90) for Na 135 mEq/L
survival for the low EF cohort was 64% (95%CI, 58-70) for Na 135 mEq/L
r survival for the normal EF cohort was 77% (95% CI, 74-80) for Na 135
F, Ejection fraction; CI, confidence interval.
gery c June 2013
FIGURE 2. Effect of hyponatremia on clinical outcomes of patients with low and normal ejection fractions by multivariable regression analysis.
See Appendix E2 for covariates included in the analysis. EF, Ejection fraction; OR, odds ratio; CI, confidence interval; HR, hazard ratio.
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Mwithout hyponatremia within each cohort of the current
study. These findings are not surprising because the most
critical factors in the development of hyponatremia in
heart failure is the reduction in cardiac output and the
degree of neurohormonal activation.17 Many patients with
decreased EF are capable of maintaining cardiac output
secondary to a compensatory increase in LV end-diastolic
volume.18 This study quantified heart failure severity by
evaluating NYHA class. Compared with normonatremia,
hyponatremic patients had a higher prevalence of NYHA
class III and IV symptoms regardless of their EF. Therefore,
preoperative hyponatremia correlates more with the overall
severity of heart failure than with EF alone.
Hyponatremia has been associated with adverse outcomes
in multiple clinical settings.1-6 However, the value of
preoperative hyponatremia to predict outcomes in patients
undergoing cardiac surgery has not been established.
Conversely, LV dysfunction is a well-established risk factor
associated with adverse outcomes after cardiac surgery pro-
cedures.7-10 LV dysfunction has been associated with
increased risk of early and late mortality after CABG,
aortic and mitral valve surgery, and combined valve
CABG.7-10 The present study demonstrated increased early
and late mortality in a large group of patients with low LV
EF undergoing a variety of cardiac surgery procedures
that are representative of the surgical practice in this
country. We expected that the coexistence of preoperative
hyponatremia with LV dysfunction may accentuate the
adverse effects of LV dysfunction on outcomes. In the
OPTIMIZE-HF registry,which included 47,000patients hos-
pitalizedwith heart failure, the combination of hyponatremia
and LV dysfunction increased the unadjusted rates of inThe Journal of Thoracic and Carhospital mortality, length of hospital stay, rehospitalization
for heart failure, and long-term mortality compared with hy-
ponatremia alone.3 In addition, hyponatremia was indepen-
dently associated with an increased risk of mortality in
patientswith normal EFand patientswith lowEF. In the pres-
ent study, preoperative hyponatremia was associated by uni-
variate analysis with postoperative complications, length of
hospital stay, and early and latemortality in both low and nor-
mal EF cohorts. However, hyponatremia was only indepen-
dently associated with adverse outcomes in patients with
preserved LV systolic function. The failure to observe an in-
dependent effect on mortality in patients with low EF is puz-
zling and led to the generation of 2 hypotheses to explain this
finding: (1) The interaction of the therapeutic intervention
(cardiac surgery) in outcomes may disrupt that association.
Contrary to patients with congestive heart failure treated
medically, cardiac surgery proceduresmay correct or amelio-
rate heart failure and disrupt the independent effect of hypo-
natremia in outcomes. (2) Hyponatremia might behave as
a marker of disease severity and neurohormonal activation
in low EF, whereas in patients with normal EF, it has an inde-
pendent and direct deleterious effect on myocardial function
that predisposes those patients to poor outcomes after sur-
gery. Elucidation of these hypotheses will require additional
studies specifically designed to address them.
Study Limitations
First, this was a single-center retrospective study, and the
results should be interpretedwithin such context. Second, de-
spite the overall large population included in the study, there
were only 245 patients (10.9%) with hyponatremia and low
EF. Third, the preoperativeEFwas determined by avariety ofdiovascular Surgery c Volume 145, Number 6 1593
FIGURE 3. Association between preoperative serum sodium and adjusted
overall mortality for patients with low EF (A) and normal EF (B). The
adjusted mortality rate increases with the severity of preoperative hypona-
tremia in the normal EF cohort (B) but not in the low EF cohort (A).Dashed
lines represent 95% CI. See Appendix E2 for covariates included in the
model. EF, Ejection fraction; CI, confidence interval.
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Mmethods (echocardiogram, ventriculogram, and others) dur-
ing standard clinical care,whichmay have resulted in consid-
erable variability in EF measurements. Fourth, low EF was
defined as an EF less than 40%. Therefore, patients with
moderate and severe LV dysfunction were included in the
low EF group. It is possible that preoperative hyponatremia
mayhavedifferent effects onoutcomes in thosegroups. Fifth,
serumsodiumlevelswere not adjusted forglucose levels.Hy-
perglycemia leads to hyponatremia by mechanisms different
than those responsible for hyponatremia in heart failure. It is
unknown whether hyponatremia secondary to hyperglyce-
mia has any adverse effects in outcomes.19CONCLUSIONS
Preoperative hyponatremia is common in patients under-
going cardiac surgery. Eighteen percent of patients with1594 The Journal of Thoracic and Cardiovascular Surnormal EF and 35% of patients with low EF have preopera-
tive hyponatremia. Although hyponatremia is independently
associated with adverse outcomes in patients with normal
EF, this study failed to demonstrate an association with ad-
verse outcomes in patients with low EF. Despite this lack
of association, preoperative hyponatremia should be ad-
dressed before surgery regardless of the patient’s EF. Further
studies are necessary to elucidate the reasons for this unex-
pected response to hyponatremia in patients with low EF.References
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APPENDIX E1. OUTCOMES DEFINITIONS
Early mortality was defined as any death that occurred dur-
ing the hospitalization in which the operation was per-
formed or after discharge from the hospital, but within 30
days of the procedure.
Late mortality included any death that occurred both after
discharge from the hospital and more than 30 days from the
operative procedure.
Complications Defined by the Society of Thoracic
Surgeons
Operative complications included (a) perioperative myo-
cardial infarction; (b) reoperation for bleeding, cardiac tam-
ponade, native or prosthetic valve dysfunction, and graft
occlusion; (c) other cardiac reoperations; and (d) noncar-
diac reoperations.
Pulmonary complications included (a) reintubation dur-
ing hospital stay, (b) ventilatory support for more than 24
hours after surgery, (c) pulmonary embolism, and (d)
pneumonia.
Infectious complications included (a) wound infections
(sternal, thoracotomy, leg, and arm incisions) and (b) sepsis.
Neurologic complications included (a) stroke, (b) tran-
sient ischemic attack, (c) comma, and (d) paralysis or
paraplegia.
Renal complications included renal failure defined as
a postoperative serum creatinine greater than 2 mg/dL, or
twice the preoperative creatinine level, or the need for renal
replacement therapy.
Other complications included (a) cardiac arrest, (b) tam-
ponade, (c) multisystem organ failure, and (d) atrial
fibrillation.
APPENDIX E2. COVARIATES INCLUDED IN
MULTIVARIABLE REGRESSION ANALYSIS
MODELS
1. Logistic operative complication model: European
System for Cardiac Operative Risk Evaluation (euro-
SCORE), inotropic medications, previous cardiac sur-
gery, cardiogenic shock, coronary artery bypass grafting
(CABG), valve surgery, stroke, surgery status (elective,
emergency, or urgent), glomerular filtration rate (GFR),
and New York Heart Association (NYHA) class.
2. Logistic infectious complication model: euroSCORE,
inotropic medications, cardiogenic shock, intra-aortic
balloon pump (IABP), arrhythmia, CABG, valve sur-
gery, other cardiac surgery, stroke, previous myocardial
infarction (MI), surgery status (elective, emergency, or
urgent), GFR, and NYHA classification.
3. Logistic pulmonary complication model: euroSCORE,
inotropic medications, IABP, arrhythmia, cardiogenic
shock, CABG, valve, ventricular assist device (VAD),
stroke, chronic obstructive pulmonary disease (COPD),
surgery status (elective, emergency, or urgent), GFR,
and NYHA class.
4. Logistic neurologic complication model: euroSCORE,
patient age, gender, previous cardiac surgery, inotropic
medications, IABP, diabetes, cardiogenic shock, ar-
rhythmia, CABG, valve surgery, VAD surgery, other
cardiac surgery, stroke, peripheral vascular disease
(PVD), previousMI, hypertension, surgery status (elec-
tive, emergency, or urgent), GFR, and NYHA class.
5. Logistic renal failure requiring dialysis model: euro-
SCORE, previous cardiac surgery, inotropic medica-
tions, cardiogenic shock, arrhythmia, CABG, valve
surgery, VAD surgery, stroke, previous MI, surgery sta-
tus (elective, emergency, or urgent), GFR, and NYHA
class.
6. Logistic other complication model: euroSCORE, pa-
tient age, gender, previous cardiac surgery, inotropic
medication, IABP, diabetes, cardiogenic shock, ar-
rhythmia, CABG, valve surgery, VAD surgery, stroke,
PVD, previous MI, COPD, surgery status (elective,
emergency, or urgent), prior GFR, and NYHA class.
7. Linear length of hospital stay model: euroSCORE, ino-
tropic medications, cardiogenic shock, arrhythmia,
CABG, valve surgery, VAD surgery, stroke, surgery
status (elective, emergency, or urgent), GFR, and
NYHA class.
8. Logistic early mortality model: patient age, GFR, euro-
SCORE, preoperative inotropic medications, VAD sur-
gery, other cardiac surgery, cardiogenic shock, and
NYHA class.
9. Cox proportional hazard late mortality model: patient
age, GFR, euroSCORE, preoperative inotropic medica-
tions, VAD surgery, other cardiac surgery, cardiogenic
shock, and NYHA classification.
10. Cox proportional hazard overall mortality model: pa-
tient age, GFR, euroSCORE, preoperative inotropic
medications, VAD surgery, cardiogenic shock, and sur-
gery status (elective, emergency, or urgent).
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FIGURE E1. Distribution of preoperative LV EF. Low EF was present in
707 patients (31.5%). A total of 550 patients (24.5%) had moderate reduc-
tion of EF (EF, 20%-39%). A total of 157 patients (7.0%) had severe re-
duction of EF (<20%). LV, Left ventricular; EF, ejection fraction.
FIGURE E2. Effect of hyponatremia on clinical outcomes of patients with low and normal ejection fractions by univariate analysis. EF, Ejection fraction;
OR, odds ratio; CI, confidence interval; HR, hazard ratio.
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